This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Ohio University, University of Montana. Active years: 2012-2022.
Company Filing History:
Years Active: 2012-2022
Title: The Innovations of Nigel Priestley
Introduction
Nigel Priestley is an accomplished inventor based in Alberton, MT (US). He has made significant contributions to the field of antimicrobial agents and antibacterial compounds. With a total of 2 patents, his work has implications for treating various microbial infections.
Latest Patents
Priestley's latest patents include "16-methyl-oxacyclohexadecan-2-one and 16-methyl-azacyclohexadecan-2-one derivatives as antimicrobial agents." These 16-membered macrolide compounds are designed to inhibit the growth of various microbial species and have utility in the treatment of systemic or topical microbial infections, including methicillin-resistant strains. Another notable patent is the "Synthesis of methyl nonactate derivatives," which details a reaction scheme that converts methyl nonactate into a variety of different triazoloamide antibacterial agents.
Career Highlights
Throughout his career, Nigel Priestley has worked with esteemed institutions such as the University of Montana and Ohio University. His research has focused on developing innovative solutions to combat bacterial infections, showcasing his dedication to improving public health.
Collaborations
Some of his notable coworkers include Andrea Stierle and Donald Stierle, who have contributed to his research endeavors.
Conclusion
Nigel Priestley's work exemplifies the spirit of innovation in the field of antimicrobial research. His patents and collaborations highlight his commitment to advancing medical science and addressing critical health challenges.